Physician profile
Alex Foxman
NPI 1013097831
$4,083.38
in general payments reported to CMS, 2019-2025
36 companies · $919 in 2025
The $919 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.89 · 2020: $78.49 · 2021: $440 · 2022: $1,066 · 2023: $724 · 2024: $776 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,418.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $832.81 | 2021-2025 | |
| Novo Nordisk INC | $677.34 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $417.39 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $320.91 | 2020-2025 | Otezla, Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $201.79 | 2024-2025 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $193.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.36 | 2019-2025 | Synjardy, Jardiance, Tradjenta |
| Pfizer INC. | $134.22 | 2024-2025 | |
| Abbott Laboratories | $131.35 | 2022-2024 | Freestyle Libre 3, Eterna |
| Novartis Pharmaceuticals Corporation | $130.76 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $116.97 | 2020-2025 | Gardasil 9, Capvaxive, Pneumovax 23 |
| Glaxosmithkline, LLC. | $109.27 | 2023-2025 | Arexvy, Shingrix |
| Eisai INC. | $70.51 | 2021-2025 | |
| Heartflow, INC. | $47.06 | 2024-2025 | |
| Lundbeck LLC | $45.99 | 2025 | Rexulti |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Foxman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.